phenol has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, L | 1 |
| Li, J | 1 |
| Wang, G | 1 |
| Sang, W | 1 |
| Xu, M | 1 |
| Li, W | 1 |
| Yan, J | 1 |
| Li, B | 1 |
| Zhang, Z | 1 |
| Zhao, Q | 1 |
| Yuan, Z | 1 |
| Fan, Q | 1 |
| Dai, Y | 1 |
| Yamazaki, Y | 1 |
| Kawano, Y | 1 |
| Yamanaka, A | 1 |
| Maruyama, S | 1 |
2 other studies available for phenol and B16 Melanoma
| Article | Year |
|---|---|
Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy.
Topics: Aniline Compounds; Animals; B7-H1 Antigen; Benzylidene Compounds; CD8-Positive T-Lymphocytes; Cell L | 2022 |
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Drug Screening Assays, Antitumor; Enz | 2009 |